舍曲林
引用

↑  drugs.com drugs.com international Sertraline （页面存档备份，存于） Page accessed May 11, 2015
1 2 3 4  Obach RS, Cox LM, Tremaine LM. . Drug Metab. Dispos. 2005, 33 (2): 262–70. PMID 15547048. doi:10.1124/dmd.104.002428.
↑  Sertraline FDA Label.  http://www.fda.gov/ohrms/dockets/ac/04/briefing/4006b1_06_zoloft-label.pdf （页面存档备份，存于）
↑  Brunton L, Chabner B, Knollman B. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, Twelfth Edition. McGraw Hill Professional; 2010.
↑  史有为主编. . 商务印书馆辞书研究中心  (编). . 北京: 商务印书馆: 1011. 2019. ISBN 978-7-100-16091-9.
↑  John M. Grohol. . Psych Central. 2014  [3 April 2015]. （原始内容存档于2015-03-31）.
↑  Sanchez, C; Reines, E. H.; Montgomery, S. A. . International Clinical Psychopharmacology. 2014, 29 (4): 185–196. PMC 4047306 . PMID 24424469. doi:10.1097/YIC.0000000000000023.
↑  . The American Society of Health-System Pharmacists.   [3 April 2011]. （原始内容存档于2016-03-08）.
↑  Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R; Matthews; Linardatos; Tell; Rosenthal. . N. Engl. J. Med. 2008, 358 (3): 252–60. PMID 18199864. doi:10.1056/NEJMsa065779.
1 2  Lépine JP, Goger J, Blashko C, Probst C, Moles MF, Kosolowski J, Scharfetter B, Lane RM; Goger; Blashko; Probst; Moles; Kosolowski; Scharfetter; Lane. . International Clinical Psychopharmacology. 2000, 15 (5): 263–71. PMID 10993128. doi:10.1097/00004850-200015050-00003.
↑  Aberg-Wistedt A, Agren H, Ekselius L, Bengtsson F, Akerblad AC; Agren; Ekselius; Bengtsson; Akerblad. . J Clin Psychopharmacol. 20 December 2000, 20 (6): 645–52. PMID 11106136. doi:10.1097/00004714-200012000-00010.
↑  Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M; Armstrong; Skrepnek; Haim Erder. . Current Medical Research and Opinion. 2007, 23 (2): 245–50. PMID 17288677. doi:10.1185/030079906X167273.
↑  Matreja, P. S.; Badyal, D. K.; Khosla, P; Deswal, R. S. . Hum Psychopharmacol. 22 October 2007, 22 (7): 477–82. PMID 17647298. doi:10.1002/hup.864.
↑  Flament MF, Lane RM, Zhu R, Ying Z; Lane; Zhu; Ying. . Int Clin Psychopharmacol. 1999, 14 (5): 259–75. PMID 10529069. doi:10.1097/00004850-199914050-00001.
↑  Cohen D. . Psychotherapy and psychosomatics. 2007, 76 (1): 5–14. PMID 17170559. doi:10.1159/000096360.
↑  Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A; Hellier; Romeo; Dewey; Knapp; Ballard; Baldwin; Bentham; Fox; Holmes; Katona; Lawton; Lindesay; Livingston; McCrae; Moniz-Cook; Murray; Nurock; Orrell; O'Brien; Poppe; Thomas; Walwyn; Wilson; Burns. . Health Technol Assess. 2007, 17 (7): 1–116. PMID 23438937. doi:10.3310/hta17070.
↑  Parker G, Roy K, Wilhelm K, Mitchell P; Roy; Wilhelm; Mitchell. . J Clin Psychiatry. 2001, 62 (2): 117–25. PMID 11247097. doi:10.4088/JCP.v62n0209.
↑  Anderson IM. . Depress Anxiety. 1998, 7 (S1): 11–7. PMID 9597346. doi:10.1002/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I.
↑  Hirschfeld RM. . J Clin Psychiatry. 1999, 60 (5): 326–35. PMID 10362442. doi:10.4088/JCP.v60n0511.
↑  Amsterdam JD. . J. Psychopharmacol. (Oxford). 1998, 12 (3 Suppl B): S99–111. PMID 9808081. doi:10.1177/0269881198012003061 (不活跃 2015-05-19).
↑  Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C; Furukawa; Salanti; Geddes; Higgins; Churchill; Watanabe; Nakagawa; Omori; McGuire; Tansella; Barbui. . The Lancet. 2009, 373 (9665): 746–758. PMID 19185342. doi:10.1016/S0140-6736(09)60046-5. 简明摘要 – The Washington Post (29 January 2009).
↑  Papakostas GI, Fava M; Fava. . Canadian Journal of Psychiatry. 2006, 51 (12): 783–90. PMID 17168253.
↑  Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS; Kiev; Shrivastava; Wisselink; Wilcox. . The Journal of Clinical Psychiatry. 57. 1996,. Suppl 2: 53–62. PMID 8626364.
↑  Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA; Segraves; Hughes; Ascher; Johnston. . The Journal of Clinical Psychiatry. 1997, 58 (12): 532–7. PMID 9448656. doi:10.4088/JCP.v58n1204.
↑  For the review, see:Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS; Gartlehner; Lohr; Gaynes; Carey. . Ann. Intern. Med. 2005, 143 (6): 415–26. PMID 16172440. doi:10.7326/0003-4819-143-6-200509200-00006.
↑  Cipriani, A; La Ferla, T; Furukawa, TA; Signoretti, A; Nakagawa, A; Churchill, R; McGuire, H; Barbui, C. . The Cochrane database of systematic reviews. 14 April 2010, (4): CD006117. PMC 4163971 . PMID 20393946. doi:10.1002/14651858.CD006117.pub4.
↑  Muijsers RB, Plosker GL, Noble S; Plosker; Noble. . Drugs & Aging. 2002, 19 (5): 377–92. PMID 12093324. doi:10.2165/00002512-200219050-00006.
↑  Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K; Nelson; Clary; Newhouse; Krishnan; Shiovitz; Weihs; Sertraline Elderly Depression Study Group. . Am J Psychiatry. 2003, 160 (7): 1277–85. PMID 12832242. doi:10.1176/appi.ajp.160.7.1277.
↑  Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV; Biederman; Stewart; Mullin; Martin; Spencer; Faraone. . The American Journal of Psychiatry. 2003, 160 (11): 1919–28. PMID 14594734. doi:10.1176/appi.ajp.160.11.1919.
↑  Flament MF, Bisserbe JC; Bisserbe. . The Journal of Clinical Psychiatry. 58. 1997,. Suppl 12: 18–22. PMID 9393392.
↑  Math SB, Janardhan Reddy YC. . medscape.com. 19 July 2007  [28 July 2009]. （原始内容存档于2021-01-25）.
↑  Blier P, Habib R, Flament MF; Habib; Flament.  (PDF). Can J Psychiatry. 2006, 51 (7): 417–30. PMID 16838823. （原始内容 (PDF)存档于2010-02-04）.
↑  Pediatric OCD Treatment Study (POTS) Team. . JAMA. 2004, 292 (16): 1969–76. PMID 15507582. doi:10.1001/jama.292.16.1969.
↑  Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV; Isolan; Oliveira; Manfro; Cordioli. . The Journal of Clinical Psychiatry. 2006, 67 (7): 1133–9. PMID 16889458. doi:10.4088/JCP.v67n0717.
↑  Jiménez-Jiménez FJ, García-Ruiz PJ; García-Ruiz. . Drugs. 2001, 61 (15): 2207–20. PMID 11772131. doi:10.2165/00003495-200161150-00005.
1 2 3  Hirschfeld RM. . Depress Anxiety. 2000, 11 (4): 139–57. PMID 10945134. doi:10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C.
1 2  Clayton AH, Stewart RS, Fayyad R, Clary CM; Stewart; Fayyad; Clary. . Arch Womens Ment Health. 2006, 9 (3): 151–7. PMID 16292466. doi:10.1007/s00737-005-0111-y.
↑  Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. . International clinical psychopharmacology. 2008-05, 23 (3): 170–179  [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
↑  Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. . International clinical psychopharmacology. 2008-05, 23 (3): 170–179  [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
↑  Walkup, John T.; Albano, Anne Marie; Piacentini, John; Birmaher, Boris; Compton, Scott N.; Sherrill, Joel T.; Ginsburg, Golda S.; Rynn, Moira A.; McCracken, James. . The New England journal of medicine. 2008-12-25, 359 (26): 2753–2766  [2019-03-30]. ISSN 0028-4793. PMC 2702984 . PMID 18974308. doi:10.1056/NEJMoa0804633. （原始内容存档于2022-06-22）.
↑  Gale, Christopher K; Millichamp, Jane. . BMJ Clinical Evidence. 2011-10-27, 2011  [2019-03-30]. ISSN 1752-8526. PMC 3275153 . PMID 22030083. （原始内容存档于2022-05-09）.
1 2 3  Marjoribanks J, Brown J, O'Brien PM, Wyatt K; Brown; O'Brien; Wyatt. . The Cochrane database of systematic reviews. 7 June 2013, 6: CD001396. PMID 23744611. doi:10.1002/14651858.cd001396.pub3.
↑  Pearlstein T. . Drugs. 2002, 62 (13): 1869–85. PMID 12215058. doi:10.2165/00003495-200262130-00004.
↑  Ackermann RT, Williams JW; Williams Jr. . J Gen Intern Med. 2002, 17 (4): 293–301. PMC 1495030 . PMID 11972726. doi:10.1046/j.1525-1497.2002.10350.x.
↑  Abdel-Hamid IA. . Current clinical pharmacology. September 2006, 1 (3): 243–54. PMID 18666749. doi:10.2174/157488406778249352.
↑  Waldinger MD. . Urol. Clin. North Am. 2007, 34 (4): 591–9, vii–viii. PMID 17983899. doi:10.1016/j.ucl.2007.08.011.
↑  McMahon CG, Porst H; Porst. . The journal of sexual medicine. October 2011, 8 (10): 2707–25. PMID 21771283. doi:10.1111/j.1743-6109.2011.02386.x.
↑  Levenson M, Holland C. . FDA.   [11 July 2008]. （原始内容存档于2017-05-17）.
↑  Stone MB, Jones ML.  (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA: 11–74. 17 November 2006  [11 July 2008]. （原始内容存档 (PDF)于2007-03-16）.
↑  Levenson M, Holland C.  (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA: 75–140. 17 November 2006  [11 July 2008]. （原始内容存档 (PDF)于2007-03-16）.
↑  R. Baselt.  8th. Foster City, California: Biomedical Publications. 2008: 1399–1400.
↑  Taylor, D; Paton, C; Shitij, K. . West Sussex: Wiley-Blackwell. 2012. ISBN 978-0-470-97948-8.
↑  White N, Litovitz T, Clancy C; Litovitz; Clancy. . Journal of Medical Toxicology. December 2008, 4 (4): 238–250. PMC 3550116 . PMID 19031375. doi:10.1007/BF03161207/pdf/13181_2009_Article_BF03161207.pdf (不活跃 2015-05-19).
↑   (PDF).   [2015-09-03]. （原始内容 (PDF)存档于2020-09-20）.
↑  Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S; Wilson; Sagrati; Hussey; Carella; Potter; Ginovart; Spencer; Cheok; Houle. . The American Journal of Psychiatry. 2004, 161 (5): 826–35. PMID 15121647. doi:10.1176/appi.ajp.161.5.826.
↑  DeVane CL, Liston HL, Markowitz JS; Liston; Markowitz. . Clinical Pharmacokinetics. 2002, 41 (15): 1247–66. PMID 12452737. doi:10.2165/00003088-200241150-00002.
↑  Kobayashi K, Ishizuka T, Shimada N, Yoshimura Y, Kamijima K, Chiba K; Ishizuka; Shimada; Yoshimura; Kamijima; Chiba. . Drug Metab. Dispos. 1999, 27 (7): 763–6. PMID 10383917.
↑  Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M; Turgeon; Vallée; Bélanger; Paquet; Lebel. . Clin. Pharmacol. Ther. 1996, 60 (5): 512–21. PMID 8941024. doi:10.1016/S0009-9236(96)90147-2.
↑  Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH; Liu; Wang; Chen; Shu; He; Zhou. . Clin. Pharmacol. Ther. 2001, 70 (1): 42–7. PMID 11452243. doi:10.1067/mcp.2001.116513.
↑
↑  Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ; Fahey; Miller; de la Garza; Goulet; Spealman; Meltzer; George; O'Dowd; Bonab; Livni; Fischman. . Eur. J. Pharmacol. 2003, 479 (1–3): 41–51. PMID 14612136. doi:10.1016/j.ejphar.2003.08.055.
↑  Ciraulo, DA; Shader, RI (编). . SpringerLink 2nd (New York, NY: Humana Press). 2011  [2015-10-04]. ISBN 978-1-60327-434-0. doi:10.1007/978-1-60327-435-7. （原始内容存档于2021-02-25）.